PLK1 was positively correlated with CD163 in prostate cancer (Pca) samples (r=0.69, p<0.01), but not in benign prostatic hypertrophy (BPH) samples (r=0.12, p=0.63) (Figure 10B). Here, PLK1 is linked to benign prostatic hyperplasia.